Deprecated: Creation of dynamic property cls_session::$session_data_table is deprecated in /www/sites/www.188bio.com/index/systems/cls_session.php on line 49
ImmunoChem/Acetyl Lysine Antibody, FITC/100 µg/ICP0385188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

ImmunoChem/Acetyl Lysine Antibody, FITC/100 µg/ICP0385

Acetyl Lysine Antibody, FITC

Catalog # Pack Size Price(USD)
ICP0385 100 µg $375.00

Quantity:

Product Description
The rabbit anti-acetyl lysine antibody is developed using acetylated KLH as the immunogen. It is affinity purified with acetyl lysine agarose, followed by conjugation with fluorescein isothiocyanate.
Immunoflourescent staining of TSA-treated and non-treated melanoma cells.
Species
Rabbit
Formulation
250 µg/mL in PBS (pH 7) with 50% glycerol
Immunogen
Acetylated KLH conjugates
Purification
Affinity chromatography with acetyl-lysine agarose
Conjugation
FITC:antibody = 10:1
Applications
For direct immunofluorescence experiments
Scientific Description
Acetylation of lysine is an important, reversible modification. The activities of some proteins are controlled by acetylation of lysine. Histone acetyltransferases (HATs) acetylate the conserved amino-terminal domains of the four core histones (H2A, H2B, H3 and H4) that contain lysine residues. Histone deacetylases (HDACs) remove the acetyl group from the same residue. [1] Acetylation/deacetylation of histones results in cell signalling processes that include gene activity, cell growth, differentiation and apoptosis. [2] In cancer and polyglutamine diseases, the regulation of protein acetylation/deacetylation is impaired (7). Numerous anti-cancer drugs target HDACs. [3]
Storage & Stability
Product is stable for several weeks at 4°C. For extended storage, store product at -20°C. Expiration date is six months from date of shipping if stored properly.

Product Specific References

  1. 1.Curr. Opin. Chem. Biol.1997.1(3): 300-308.doi:10.1016/S1367-5931(97)80066-X.
  2. 2.Curr. Cancer Drug Targets.2004.4(2): 205-218. doi:10.2174/1568009043481560.
新闻动态
行业前沿
技术文章
最新产品